A BMJ meta-analysis of 23 randomized clinical trials found that low-carbohydrate diets pushed type 2 diabetes into remission more often than control diets at six months. The review, published Jan. 13, 2021, pooled 1,357 participants and defined low-carb eating as fewer than 130 grams a day, or less than 26% of a 2,000-calorie diet.
The remission signal was strongest early. At six months, 57% of people on low-carb plans, 76 of 133 participants, met the trial definition of remission, compared with 31% of controls, 41 of 131 participants. The reported risk difference was 0.32, with a 95% confidence interval from 0.17 to 0.47. In the review, remission meant an HbA1c below 6.5% with or without diabetes medication, or a fasting glucose below 7.0 mmol/L.
The findings matter for keto readers because the paper did not treat carbohydrate restriction as a miracle fix. The authors rated the certainty of evidence as moderate to low, and only 40.6% of outcomes were judged to be at low risk of bias. Still, they reported no significant or clinically important between-group differences in adverse events or blood lipids at six and 12 months, which supports the idea that a well-run low-carb plan can be used without obvious short-term harm in trial settings.
The catch is durability. The BMJ paper said the benefits diminished by 12 months, and remission definitions remain debated. That keeps the result squarely in the remission category, not a cure. It points to a state where blood sugar improves enough to meet a trial threshold, while the underlying tendency toward type 2 diabetes can still return if the diet slips or weight comes back.
The broader clinical landscape shows why this is still getting attention. The American Diabetes Association’s Standards of Care in Diabetes, released Dec. 9, 2024, continue to emphasize evidence-based eating patterns. In England, NHS England and Diabetes UK run the Type 2 Diabetes Path to Remission Programme for eligible adults with type 2 diabetes and overweight or obesity, using low-calorie total diet replacement. Other remission strategies, including low-calorie approaches studied in DiRECT, reinforce that low-carb is one route among several, not the only one. For keto readers, the practical takeaway is clear: the strongest evidence still favors patients who can adhere for months, stay medically supervised, and treat diet quality as part of the result, not an afterthought.
Every story on Keto Diet Magazine is assembled by an automated editorial system that works from verified research, official records, and credible reporting, then clears automated accuracy and moderation checks before it goes live. The standards that system follows are set and overseen by the people who run the publication. Read our full editorial policy.
Did this article answer your question?
